Eight postoperative goats with intestinal trauma were orally supplemented with cysteamine hydrochloride (CS) in a dose of 45 (Exp, n=4) or 0 mg·kg -1 BW per day (Con, n=4), respectively, to investigate the effects of CS on mucosal morphology. The duodenal epithelial cells of cows (n=3) were cultured to determine DNA synthesis and anti-oxidation capacity. Compared with Con the villous height in duodenum (DM) and in proximal jejunum (PJ) was enhanced signifi cantly (P<0.05) in Exp, the crypt depth also increased in these two tissues (P=0.08, P=0.06). The RNA/ DNA ratio decreased in Exp for DM (P=0.10) and for PJ (P<0.05). CS also enhanced mucosal γ-glutamyl transferase activity in the DM or PJ (P<0.05), and the alkaline phosphatase activity in the PJ (P=0.08). These data indicated that CS induced mucosa hyperplasia rather than hypertrophy in DM and PJ. This was supported by in vitro experiment, in which CS stimulated DNA synthesis and enhanced total anti-oxidation capacity and the intracellular glutathione concentration in cultured duodenal cells of cows (P<0.05).
INTRODUCTION
Goats, equipped with permanent fi stula in rumen and duodenum, are widely used as experimental models for nutritional and physiological studies. However, in postoperative animal with surgical trauma the intestinal mucosal structure and function are usually altered, leads to mucosal atrophy, increased intestinal permeability, bacterial translocation and infection (Fink, 1991) , which partly associated with depressed immune activity (Shen and Xie, 2004) .
Cysteamine (2-mercaptoethylamine) exerts multiple effects on mammalian physiology. Of its several functions, cysteamine acts as a somatostatin (SS)-inhibitor, depleting SS in the brain and peripheral tissues and augmenting growth hormone (GH) concentration (Beal and Martin, 1984; McLeod et al., 1995) . Cysteamine also acts as anti-oxidant in vivo (Suzy et al., 2002) . Moreover, cysteamine hydrochloride attenuated the suppression of IL-2 and lymphocyte proliferation induced by surgery stress (Shen and Xie, 2004) . It is accepted that GH-IGF-1 axis promoting cell proliferation in most cell types. Moreover, the antioxidation (Miller, 1999; Babu et al., 2001 ) is closely associated with intestinal mucosal growth. Accordingly, cysteamine could be a potential growth-promoting agent for treatment of intestinal trauma.
In this study the effects of cysteamine hydrochloride on mucosal regeneration of small intestine was investigated by using the postoperative goats, suffered from surgery trauma in intestine, as animal model. The effect of cysteamine hydrochloride on DNA synthesis and anti-oxidation were estimated by administered cysteamine to duodenal cells of cow in primary culture.
MATERIAL AND METHODS
Eight male postoperative goats (5-month, BW 21.4±2.6 kg), suffered from surgery trauma in intestinal mucosa, were randomly allocated into control (Con, n=4) and experimental group (Exp, n=4). They were offered concentrate (100 g·d -1 ) and hay ad libitum. The goats in Exp group were orally supplemented with cysteamine hydrochloride compound (CS) in a dose of 45 mg·kg -1 BW per day (intestinal-lysis microcapsules, containing 30% of cysteamine, donation of Shanghai Walcom Bio-Chem Co., Ltd.) for 4 weeks.
Blood was sampled from jugular vein in both Exp (n=3) and Con (n=3) groups at the 14 th day (since the commencement of the feeding trial) to examine the PHAinduced lymphocyte transformation, ascertained by incorporation of 3 H-thymidine ( 3 H-TdR, Shanghai Atomic Energy Institute, Shanghai, China) into DNA (Yang et al., 2006) . The lymphocyte proliferation rate was expressed as stimulating index (SI), SI = cpm (PHA+)/cpm(PHA-).
At the slaughter, the fresh tissues of duodenum, jejunum and ileum were sampled to determine the villous size and crypt depth (Zitnan et al., 2003) The mucosa of these tissues was collected for analysis of mucosal composition of protein, nucleic acid, the activities of alkaline phosphatase (AP) and γ-glutamyl transferase (γ-GT) by using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).
The mid-duodenum were collected from cows and trypsinized to get individual cells. These individual epithelial cells were incubated in the medium of MEM (GIBCO) added with 8% foetal calf serum, 2 mmol/l L-glutamine and antibiotics. Cysteamine was administered at dose of 10 µg/ml (Exp) or 0 µg/ml (Con) for 20 h followed by 3 H-TdR (1 μCi/ml) treatment for another 8 h. The cells were collected to determine the DNA synthesis in S phase (characterized by 3 H-TdR incorporation into DNA), the total anti-oxidation capacity (T-AOC) and the intracellular glutathione concentration (GSH) was determined by using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).
Data were expressed as mean±SEM. The signifi cance was determined by Student`s t-test. P<0.05 was considered to be signifi cant. The program of SPSS for windows (vision 10.0.0, SPSS Inc., Chicago, IL, USA) was used for statistical calculation.
RESULTS
The oral cysteamine hydrochloride administration altered the appearance of mucosa in duodenum and proximal jejunum ( Table 1 ). The villous height in Exp groups of duodenum (P<0.05) and proximal jejunum (P<0.05) is greater than that in Con group. This was accompanied by enhanced crypt depth in mucosa of duodenum (P=0.08) and proximal jejunum (P=0.06). Concentrations of mucosal DNA in duodenum and proximal jejunum (Table 2 ) are higher in Exp than that in Con goats (P<0.05). The RNA concentration did not differ between groups. Therefore, the ratio of RNA/DNA, compared with Con, was reduced in Exp of duodenum (P=0.10) and of proximal jejunum (P<0.05). The protein contents of Exp increased in duodenum (P=0.08) and in proximal jejunum (P=0.10), the γ-GT activity increased in duodenum (P<0.05) and proximal jejunum (P<0.05), the AP activity however, enhanced only in proximal jejunum (P=0.08) but not in other intestinal sections.
Cysteamine hydrochloride administration did not alter the mucosal morphology or mucosal compositions in distal jejunum or ileum. There were no differences between Exp and Con groups for villous height, crypt depth or concentrations of DNA, RNA or protein in distal jejunum or ileum. Neither γ-GT nor AP activities varied in both groups for distal jejunum or ileum. The isolated duodenal epithelial cells in primary culture responded to cysteamine hydrochloride positively (Table 3) . Incorporation of 2 cells from mid-duodenum were isolated, incubated and treated with cysteamine 10 µg/ml (Exp) or 0 µg/ml (Con)
DISCUSSION
In current study the enlarged villous length in duodenum and proximal jejunum of Exp group suggest that cysteamine accelerates the renewal of mucosa. This postulate is supported by observations that duodenal and proximal jejunal RNA/DNA ration reduced in goats orally administered with cysteamine, and DNA synthesis increased in duodenal cells in primary cell culture treated with cysteamine. It is therefore concluded that hyperplasia rather than hypertrophy in this study is induced by cysteamine in intestinal mucosa, because the increased DNA synthesis in crypt cells (Potten, 1998) and the enlarged crypts depth occurred synchronously.
Previous study reported that glutamine increases intestinal villous height, stimulates gut mucosal cellular proliferation, and maintains mucosal integrity (Miller, 1999) . The effectiveness of glutamine appears to be mediated via glutathione synthesis (Babu et al., 2001 ). In present study cysteamine treatment leads to a marked increment of intracellular glutathione synthesis, which is benefi t to mucosal regeneration.
CONCLUSIONS
Oral cysteamine administration accelerated the regeneration of mucosa in terms of morphology, compositions and enzyme activities for duodenum and proximal jejunum with surgery trauma. These effects could be the result of enhanced antioxidant capacity and restoring the immune activity stimulated by cysteamine hydrochloride, in addition to its long been recognized effects of depletion of somatostatin and augment of growth hormone and IGF-1 concentrations on intestinal mucosa.
